Nrf2 activation in the treatment of neurodegenerative diseases

A focus on its role in mitochondrial bioenergetics and function

Noemí Esteras, Albena T. Dinkova-Kostova, Andrey Y. Abramov

Research output: Contribution to journalReview article

Abstract

The nuclear factor erythroid-derived 2 (NF-E2)-related factor 2 (Nrf2) is a transcription factor well-known for its function in controlling the basal and inducible expression of a variety of antioxidant and detoxifying enzymes. As part of its cytoprotective activity, increasing evidence supports its role in metabolism and mitochondrial bioenergetics and function. Neurodegenerative diseases are excellent candidates for Nrf2-targeted treatments. Most neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia and Friedreich's ataxia are characterized by oxidative stress, misfolded protein aggregates, and chronic inflammation, the common targets of Nrf2 therapeutic strategies. Together with them, mitochondrial dysfunction is implicated in the pathogenesis of most neurodegenerative disorders. The recently recognized ability of Nrf2 to regulate intermediary metabolism and mitochondrial function makes Nrf2 activation an attractive and comprehensive strategy for the treatment of neurodegenerative disorders. This review aims to focus on the potential therapeutic role of Nrf2 activation in neurodegeneration, with special emphasis on mitochondrial bioenergetics and function, metabolism and the role of transporters, all of which collectively contribute to the cytoprotective activity of this transcription factor.

Original languageEnglish (US)
Pages (from-to)383-400
Number of pages18
JournalBiological Chemistry
Volume397
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

NF-E2-Related Factor 2
Neurodegenerative diseases
Neurodegenerative Diseases
Energy Metabolism
Chemical activation
Metabolism
Transcription Factors
Friedreich Ataxia
Aptitude
Oxidative stress
Heat-Shock Proteins
Parkinson Disease
Alzheimer Disease
Oxidative Stress
Antioxidants
Inflammation
Enzymes
Therapeutics

Keywords

  • bioenergetics
  • GSK-3
  • Keap1
  • mitochondria
  • neurodegeneration
  • Nrf2

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Biology

Cite this

Nrf2 activation in the treatment of neurodegenerative diseases : A focus on its role in mitochondrial bioenergetics and function. / Esteras, Noemí; Dinkova-Kostova, Albena T.; Abramov, Andrey Y.

In: Biological Chemistry, Vol. 397, No. 5, 01.05.2016, p. 383-400.

Research output: Contribution to journalReview article

Esteras, Noemí ; Dinkova-Kostova, Albena T. ; Abramov, Andrey Y. / Nrf2 activation in the treatment of neurodegenerative diseases : A focus on its role in mitochondrial bioenergetics and function. In: Biological Chemistry. 2016 ; Vol. 397, No. 5. pp. 383-400.
@article{2c08c6bf36fe452d9b39028ff2b97ef4,
title = "Nrf2 activation in the treatment of neurodegenerative diseases: A focus on its role in mitochondrial bioenergetics and function",
abstract = "The nuclear factor erythroid-derived 2 (NF-E2)-related factor 2 (Nrf2) is a transcription factor well-known for its function in controlling the basal and inducible expression of a variety of antioxidant and detoxifying enzymes. As part of its cytoprotective activity, increasing evidence supports its role in metabolism and mitochondrial bioenergetics and function. Neurodegenerative diseases are excellent candidates for Nrf2-targeted treatments. Most neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia and Friedreich's ataxia are characterized by oxidative stress, misfolded protein aggregates, and chronic inflammation, the common targets of Nrf2 therapeutic strategies. Together with them, mitochondrial dysfunction is implicated in the pathogenesis of most neurodegenerative disorders. The recently recognized ability of Nrf2 to regulate intermediary metabolism and mitochondrial function makes Nrf2 activation an attractive and comprehensive strategy for the treatment of neurodegenerative disorders. This review aims to focus on the potential therapeutic role of Nrf2 activation in neurodegeneration, with special emphasis on mitochondrial bioenergetics and function, metabolism and the role of transporters, all of which collectively contribute to the cytoprotective activity of this transcription factor.",
keywords = "bioenergetics, GSK-3, Keap1, mitochondria, neurodegeneration, Nrf2",
author = "Noem{\'i} Esteras and Dinkova-Kostova, {Albena T.} and Abramov, {Andrey Y.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1515/hsz-2015-0295",
language = "English (US)",
volume = "397",
pages = "383--400",
journal = "Biological Chemistry",
issn = "1431-6730",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "5",

}

TY - JOUR

T1 - Nrf2 activation in the treatment of neurodegenerative diseases

T2 - A focus on its role in mitochondrial bioenergetics and function

AU - Esteras, Noemí

AU - Dinkova-Kostova, Albena T.

AU - Abramov, Andrey Y.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - The nuclear factor erythroid-derived 2 (NF-E2)-related factor 2 (Nrf2) is a transcription factor well-known for its function in controlling the basal and inducible expression of a variety of antioxidant and detoxifying enzymes. As part of its cytoprotective activity, increasing evidence supports its role in metabolism and mitochondrial bioenergetics and function. Neurodegenerative diseases are excellent candidates for Nrf2-targeted treatments. Most neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia and Friedreich's ataxia are characterized by oxidative stress, misfolded protein aggregates, and chronic inflammation, the common targets of Nrf2 therapeutic strategies. Together with them, mitochondrial dysfunction is implicated in the pathogenesis of most neurodegenerative disorders. The recently recognized ability of Nrf2 to regulate intermediary metabolism and mitochondrial function makes Nrf2 activation an attractive and comprehensive strategy for the treatment of neurodegenerative disorders. This review aims to focus on the potential therapeutic role of Nrf2 activation in neurodegeneration, with special emphasis on mitochondrial bioenergetics and function, metabolism and the role of transporters, all of which collectively contribute to the cytoprotective activity of this transcription factor.

AB - The nuclear factor erythroid-derived 2 (NF-E2)-related factor 2 (Nrf2) is a transcription factor well-known for its function in controlling the basal and inducible expression of a variety of antioxidant and detoxifying enzymes. As part of its cytoprotective activity, increasing evidence supports its role in metabolism and mitochondrial bioenergetics and function. Neurodegenerative diseases are excellent candidates for Nrf2-targeted treatments. Most neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia and Friedreich's ataxia are characterized by oxidative stress, misfolded protein aggregates, and chronic inflammation, the common targets of Nrf2 therapeutic strategies. Together with them, mitochondrial dysfunction is implicated in the pathogenesis of most neurodegenerative disorders. The recently recognized ability of Nrf2 to regulate intermediary metabolism and mitochondrial function makes Nrf2 activation an attractive and comprehensive strategy for the treatment of neurodegenerative disorders. This review aims to focus on the potential therapeutic role of Nrf2 activation in neurodegeneration, with special emphasis on mitochondrial bioenergetics and function, metabolism and the role of transporters, all of which collectively contribute to the cytoprotective activity of this transcription factor.

KW - bioenergetics

KW - GSK-3

KW - Keap1

KW - mitochondria

KW - neurodegeneration

KW - Nrf2

UR - http://www.scopus.com/inward/record.url?scp=84964922374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964922374&partnerID=8YFLogxK

U2 - 10.1515/hsz-2015-0295

DO - 10.1515/hsz-2015-0295

M3 - Review article

VL - 397

SP - 383

EP - 400

JO - Biological Chemistry

JF - Biological Chemistry

SN - 1431-6730

IS - 5

ER -